KRAS and gastric cancer: The most common genetic alterations in gastric cancer comprise among others, mutations in genes encoding for the tumour suppressor p53, the small GTPase KRAS, phosphoinositide-3 kinase (PI3K), but also members of the epidermal growth factor receptor (EGFR) family, including EGFR and ErbB2 [53,54].